Antihistamines for Postacute Sequelae of SARS-CoV-2 Infection

dc.contributor.authorPinto, Melissa D.
dc.contributor.authorLambert, Natalie
dc.contributor.authorDowns, Charles A.
dc.contributor.authorAbrahim, Heather
dc.contributor.authorHughes, Thomas D.
dc.contributor.authorRahmani, Amir M.
dc.contributor.authorBurton, Candace W.
dc.contributor.authorChakraborty, Rana
dc.contributor.departmentMedicine, School of Medicineen_US
dc.date.accessioned2022-07-26T16:05:30Z
dc.date.available2022-07-26T16:05:30Z
dc.date.issued2022-03-01
dc.description.abstractPostacute sequelae of SARS-CoV2 (PASC) infection is an emerging global health crisis, variably affecting millions worldwide. PASC has no established treatment. We describe 2 cases of PASC in response to opportune administration of over-the-counter antihistamines, with significant improvement in symptoms and ability to perform activities of daily living. Future studies are warranted to understand the potential role of histamine in the pathogenesis of PASC and explore the clinical benefits of antihistamines in the treatment of PASC.en_US
dc.eprint.versionFinal published versionen_US
dc.identifier.citationPinto, M. D., Lambert, N., Downs, C. A., Abrahim, H., Hughes, T. D., Rahmani, A. M., Burton, C. W., & Chakraborty, R. (2022). Antihistamines for Postacute Sequelae of SARS-CoV-2 Infection. The Journal for Nurse Practitioners, 18(3), 335–338. https://doi.org/10.1016/j.nurpra.2021.12.016en_US
dc.identifier.issn1555-4155en_US
dc.identifier.urihttps://hdl.handle.net/1805/29643
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.relation.isversionof10.1016/j.nurpra.2021.12.016en_US
dc.relation.journalThe Journal for Nurse Practitionersen_US
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.sourcePublisheren_US
dc.subjectantihistamineen_US
dc.subjectCOVID-19en_US
dc.subjectlong-COVIDen_US
dc.titleAntihistamines for Postacute Sequelae of SARS-CoV-2 Infectionen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Pinto2022Antihistamines-CCBYNCND.pdf
Size:
1.15 MB
Format:
Adobe Portable Document Format
Description:
Article
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.99 KB
Format:
Item-specific license agreed upon to submission
Description: